We have shown that DNA-PK inhibitors such as AZD7648 enhance the anti-cancer effects of Top2 poisons by expanding the population of targeted cells to include the non-proliferating, but transcriptionally active cells prevalent in the tumor microenvironment. Here, PRKDC is linked to cancer.